UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Repeat CRS/HIPEC: It Comes Down to Tumor Biology and Ability to Achieve a Complete CRS

Annals of surgical oncology, 2022-06, Vol.29 (6), p.3366-3368

Votanopoulos, Konstantinos I.

2022

Volltextzugriff (PDF)

Model of Patient-Specific Immune-Enhanced Organoids for Immunotherapy Screening: Feasibility Study

Annals of surgical oncology, 2020-06, Vol.27 (6), p.1956-1967

2020

Volltextzugriff (PDF)

Organoid Platform in Preclinical Investigation of Personalized Immunotherapy Efficacy in Appendiceal Cancer: Feasibility Study

Clinical cancer research, 2021-09, Vol.27 (18), p.5141-5150

2021

Volltextzugriff (PDF)

Personalized Identification of Optimal HIPEC Perfusion Protocol in Patient-Derived Tumor Organoid Platform

Annals of surgical oncology, 2020-12, Vol.27 (13), p.4950-4960

2020

Volltextzugriff (PDF)

ASO Author Reflections: Co-cultured Lymph Node and Tumor Organoids as a Platform for the Creation of Adaptive Immunity and Predict Response to Immunotherapy

Annals of surgical oncology, 2020-06, Vol.27 (6), p.1968-1969

2020

Volltextzugriff (PDF)

Immersion Bioprinting of Tumor Organoids in Multi-Well Plates for Increasing Chemotherapy Screening Throughput

Micromachines (Basel), 2020-02, Vol.11 (2), p.208

2020

Volltextzugriff (PDF)

Cell Viability Assays in Three-Dimensional Hydrogels: A Comparative Study of Accuracy

Tissue engineering. Part C, Methods, 2021-07, Vol.27 (7), p.401-410

2021

Volltextzugriff (PDF)

Intraperitoneal Chemotherapy for Peritoneal Surface Malignancy: Experience with 1,000 Patients

Journal of the American College of Surgeons, 2014-04, Vol.218 (4), p.573-585

2014

Volltextzugriff (PDF)

In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening

Scientific reports, 2018-02, Vol.8 (1), p.2886-12, Article 2886

2018

Volltextzugriff (PDF)

Patient-Specific Sarcoma Organoids for Personalized Translational Research: Unification of the Operating Room with Rare Cancer Research and Clinical Implications

Annals of surgical oncology, 2022-11, Vol.29 (12), p.7354-7367

2022

Volltextzugriff (PDF)

Application of immune enhanced organoids in modeling personalized Merkel cell carcinoma research

Scientific reports, 2022-08, Vol.12 (1), p.13865-13865, Article 13865

2022

Volltextzugriff (PDF)

Exploring the Relationship: Low-Grade Appendiceal Mucinous Neoplasms (LAMN) and Mucinous Adenocarcinoma as Phases of the Same Disease Spectrum

Annals of surgical oncology, 2023-11, Vol.30 (12), p.6976-6977

2023

Volltextzugriff (PDF)

Immuno-reactive cancer organoid model to assess effects of the microbiome on cancer immunotherapy

Scientific reports, 2022-06, Vol.12 (1), p.9983-9983, Article 9983

2022

Volltextzugriff (PDF)

Reply to: Do surgical margins affect the overall survival in patients with soft tissue sarcomas?

Journal of surgical oncology, 2021-05, Vol.123 (8), p.1850-1850

2021

Volltextzugriff (PDF)

Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study

Annals of surgical oncology, 2019-01, Vol.26 (1), p.139-147

2019

Volltextzugriff (PDF)

A Multicenter Randomized Trial to Evaluate Hematologic Toxicities after Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin or Mitomycin in Patients with Appendiceal Tumors

Journal of the American College of Surgeons, 2018-04, Vol.226 (4), p.434-443

2018

Volltextzugriff (PDF)

Delivery of an ectonucleotidase inhibitor with ROS-responsive nanoparticles overcomes adenosine-mediated cancer immunosuppression

Science translational medicine, 2022-06, Vol.14 (648)

2022

Volltextzugriff (PDF)

Optimal Adjuvant Treatment Approach After Upfront Resection of Pancreatic Cancer: Revisiting the Role of Radiation Based on Pathologic Features

Annals of surgery, 2021-12, Vol.274 (6), p.1058-1066

2021

Volltextzugriff (PDF)

Expert Commentary on Appendiceal Neoplasms

Diseases of the colon & rectum, 2017-12, Vol.60 (12), p.1239-1240

Votanopoulos, Konstantinos I

2017

Volltextzugriff (PDF)

ASO Author Reflections: Innovative HIPEC Organoid Models and Mucolytics: Targeted Therapeutic Use of Bromelain for Appendiceal Cancer

Annals of surgical oncology, 2024-08, Vol.31 (8), p.5402-5403

2024

Volltextzugriff (PDF)

Switching Perfusion Agents for Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: Surgical Dogma or Evidence-Based Practice?

Annals of surgical oncology, 2023, Vol.30 (1), p.384-391

2023

Volltextzugriff (PDF)

Utility of Neoadjuvant Chemotherapy for Peritoneal Carcinomatosis Secondary to High-Grade Appendiceal Neoplasms for Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy

Annals of surgical oncology, 2022-04, Vol.29 (4), p.2641-2648

2022

Volltextzugriff (PDF)

Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Cancers with Peritoneal Metastasis: A 30-year Institutional Experience

Annals of surgical oncology, 2022-06, Vol.29 (6), p.3436-3445

2022

Volltextzugriff (PDF)

Prognostic Factors and Significance of Gastrointestinal Leak After Cytoreductive Surgery (CRS) with Heated Intraperitoneal Chemotherapy (HIPEC)

Annals of surgical oncology, 2017-04, Vol.24 (4), p.890-897

2017

Volltextzugriff (PDF)

Incidence, Risk Factors, and Outcomes from Conversion of Low-Grade to High-Grade Appendiceal Neoplasms for Patients Undergoing Multiple Cytoreductive Surgeries with Hyperthermic Intraperitoneal Chemotherapy

Annals of surgical oncology, 2022, Vol.29 (1), p.205-211

2022

Volltextzugriff (PDF)

1 – 25 von 290

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(281)
Mit Volltextzugriff
(255)

Publikationsform

Sprache

Englisch
(289)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Repeat CRS/HIPEC: It Comes Down to Tumor Biology and Ability to Achieve a Complete CRS

Model of Patient-Specific Immune-Enhanced Organoids for Immunotherapy Screening: Feasibility Study

Organoid Platform in Preclinical Investigation of Personalized Immunotherapy Efficacy in Appendiceal Cancer: Feasibility Study

Personalized Identification of Optimal HIPEC Perfusion Protocol in Patient-Derived Tumor Organoid Platform

ASO Author Reflections: Co-cultured Lymph Node and Tumor Organoids as a Platform for the Creation of Adaptive Immunity and Predict Response to Immunotherapy

Immersion Bioprinting of Tumor Organoids in Multi-Well Plates for Increasing Chemotherapy Screening Throughput

Cell Viability Assays in Three-Dimensional Hydrogels: A Comparative Study of Accuracy

Intraperitoneal Chemotherapy for Peritoneal Surface Malignancy: Experience with 1,000 Patients

In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening

Patient-Specific Sarcoma Organoids for Personalized Translational Research: Unification of the Operating Room with Rare Cancer Research and Clinical Implications

Application of immune enhanced organoids in modeling personalized Merkel cell carcinoma research

Exploring the Relationship: Low-Grade Appendiceal Mucinous Neoplasms (LAMN) and Mucinous Adenocarcinoma as Phases of the Same Disease Spectrum

Immuno-reactive cancer organoid model to assess effects of the microbiome on cancer immunotherapy

Reply to: Do surgical margins affect the overall survival in patients with soft tissue sarcomas?

Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study

A Multicenter Randomized Trial to Evaluate Hematologic Toxicities after Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin or Mitomycin in Patients with Appendiceal Tumors

Delivery of an ectonucleotidase inhibitor with ROS-responsive nanoparticles overcomes adenosine-mediated cancer immunosuppression

Optimal Adjuvant Treatment Approach After Upfront Resection of Pancreatic Cancer: Revisiting the Role of Radiation Based on Pathologic Features

Expert Commentary on Appendiceal Neoplasms

ASO Author Reflections: Innovative HIPEC Organoid Models and Mucolytics: Targeted Therapeutic Use of Bromelain for Appendiceal Cancer

Switching Perfusion Agents for Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: Surgical Dogma or Evidence-Based Practice?

Utility of Neoadjuvant Chemotherapy for Peritoneal Carcinomatosis Secondary to High-Grade Appendiceal Neoplasms for Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy

Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Cancers with Peritoneal Metastasis: A 30-year Institutional Experience

Prognostic Factors and Significance of Gastrointestinal Leak After Cytoreductive Surgery (CRS) with Heated Intraperitoneal Chemotherapy (HIPEC)

Incidence, Risk Factors, and Outcomes from Conversion of Low-Grade to High-Grade Appendiceal Neoplasms for Patients Undergoing Multiple Cytoreductive Surgeries with Hyperthermic Intraperitoneal Chemotherapy

Suchergebnisse filtern